The five research papers published in this issue paint a bleak picture of health in the USA, with geographical, racial, ...
Technologies developed by UC San Diego and Scripps Research teams will map the human eye-brain connectome, extend the ...
A phase one clinical trial exploring a novel cell-based immunotherapy for breast cancer has been published in JAMA Oncology.
To address fundamental gaps in our knowledge about women’s health, the National Institutes of Health should form a new ...
Beta-blocker therapy was associated with a lower annualized hazard of receiving a clinical diagnosis of Huntington's disease ... (Oza, 12/4) Today JAMA published a research letter spotlighting the ...
New research challenges the notion that tumors operate as 'two-speed' entities. Scientists from the University of Cologne and ...
The FDA has granted accelerated approval to zenocutuzumab for treating patients with advanced pancreatic cancer or non-small cell lung cancer with an alteration called an NRG1 gene fusion, based on a ...
Thermo Fisher's patent activity and acquisition strategy support growth. Find out why TMO stock is poised for continued ...
In a comprehensive Genomic Press Interview, distinguished psychiatrist Professor Peter Falkai suggests promising new ...
ShiraTronics has commenced the pivotal RELIEV-CM2 CLINICAL Study of its implantable neuromodulation therapy, designed for ...
Tribe Clinical Research in Greenville has announced the launch of a new trial for a drug centered around Alzheimer's ...